In the first half of his presentation at eyeforpharma’s Oncology Summit Europe conference in January of this year, Uday Bose, European marketing director for GlaxoSmithKline Oncology, spoke about th
(Apr 30, 2008)
Oncology
Market access: obstacles and opportunities (Part I)
Uday Bose wants the pharma industry to stop regarding market access as a burden.
(Apr 30, 2008)Oncology marketing: Brand communication now and in the future
Gary Hendler, associate VP of global oncology marketing at sanofi-aventis, is trying to unpick the question of what, if anything, is special or different about marketing in oncology as compared to oth
(Apr 28, 2008)Oncology marketing for the 21st century
Market access and non-prescribing decision-makers are the key to successful oncology marketing. Industry must wake up to this if it is to get its drugs used, reports Peter Mansell
(Apr 24, 2008)Seeing (the future) clearly: pharma in 2020
At eyeforpharma’s Oncology Summit Europe in January, Professor Gordon McVie of the European Institute of Oncology in Milan spoke about his visions for oncology pharma in the year 2020.
(Apr 23, 2008)Upcoming Events:
